FDA Inspection 1300034 — South Florida Institute For Reproductive Medicine, P.A.
The FDA completed an inspection of South Florida Institute For Reproductive Medicine, P.A. on Jan 22, 2026 in South Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 22, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- South Miami, FL (United States)